Table 2.
Factors associated with LS measured under three posture conditions in univariate analyses
| Characteristics | Supine LSM | Seated LSM | Standing LSM | |||
| rs | p | rs | p | rs | p | |
| Age (per year) | - | 0.104 | - | 0.106 | –0.270 | 0.034* |
| Weight (kg) | 0.410 | < 0.001* | 0.308 | 0.015* | 0.322 | 0.011* |
| BMI (kg/m2) | 0.425 | < 0.001* | 0.268 | 0.035* | - | 0.086 |
| SCD (mm) | 0.370 | 0.003* | 0.277 | 0.029* | 0.260 | 0.041* |
| WC (cm) | 0.467 | < 0.001* | 0.369 | 0.003* | 0.345 | 0.006* |
| CAP value (dB/m) | - | 0.154 | - | 0.624 | - | 0.648 |
| Median [IQR] | p | Median [IQR] | p | Median [IQR] | p | |
| Steatosis |
Absent, 6.5 [11]; Present, 9.2 [7] |
0.849 | Absent, 7.8 [10]; Present, 7.3 [6] | 0.877 | Absent, 7.2 [10]; Present, 7.9 [6] | 0.767 |
| Sex |
Male, 10.2 [10]; Female, 6.3 [8] |
0.193 |
Male, 8.3 [9]; Female, 7.0 [6] |
0.127 |
Male, 9.2 [9]; Female, 6.6 [6] |
0.066 |
| Overweight / obesity |
Absent, 5.5 [6]; Present, 12.2 [5] |
< 0.001* | Absent, 6.8 [4]; Present, 11.5 [7] | 0.008* | Absent, 6.7 [4]; Present, 12.0 [7] | 0.017* |
| Hypertension |
Absent, 6.2 [9]; Present, 10.6 [9] |
0.187 | Absent, 7.3 [8]; Present, 8.0 [10] | 0.464 | Absent, 7.9 [8]; Present, 9.5 [9] | 0.330 |
| Type 2 DM |
Absent, 5.8 [8]; Present, 11.8 [5] |
0.013* | Absent, 6.9 [7]; Present, 11.1 [7] | 0.032* | Absent, 7.1 [7]; Present, 11.3 [7] | 0.111 |
| Dyslipidaemia |
Absent, 6.2 [9]; Present, 10.2 [7] |
0.627 | Absent, 7.2 [9]; Present, 8.0 [7] | 0.527 | Absent, 7.9 [7]; Present, 9 [7] | 0.889 |
| Metabolic syndrome |
Absent, 6.2 [9]; Present, 11.0 [9] |
0.119 | Absent, 7.3 [7]; Present, 10.5 [7] | 0.128 | Absent, 7.5 [7]; Present, 9.9 [9] | 0.293 |
| Biopsy-proven fibrosis |
No, 4.6 [1]; Yes, 13.1 [7] |
< 0.001* |
No, 5.1 [2]; Yes, 12.7 [7] |
< 0.001* |
No, 6.2 [2]; Yes, 13.0 [7] |
< 0.001* |
Age, weight, BMI, SCD, WC waist circumference were analysed by Spearman's correlation test; sex, overweight / obesity, presence of steatosis, hypertension, DM, dyslipidaemia, metabolic syndrome, and a history of biopsy-proven liver fibrosis were analysed by unpaired t-test or Mann–Whitney U test, where appropriate
* p ≤ 0.05
BMI Body mass index, SCD Skin-liver capsule distance, DM Diabetes mellitus, WC Wwaist circumference, CAP Controlled attenuation parameter, rs Spearman's rank correlation coefficient